| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/24/2006 | WO2006087548A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 08/24/2006 | WO2006087404A1 Stabilised amorphous calcium atorvastatin and production method thereof |
| 08/24/2006 | WO2006063829A3 Methamphetamine derivatives and conjugates for immunoassay |
| 08/24/2006 | WO2005004810A3 Arylsulfonamide derivatives |
| 08/24/2006 | US20060189814 Process for the synthesis of peptides containing a 4-hydroxy-proline substructure |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189676 Pyrrolcarboxamides and Pyrrolcarbothioamides |
| 08/24/2006 | US20060189663 Pyrrole-2,5-dithione derivatives as liver x receptor modulators |
| 08/24/2006 | US20060189577 Tyrosine kinase inhibitors |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | DE102005008033A1 Agent used to combat animal parasites and to prepare insecticide and acaricide agents, comprises a pyrrole or pyrrolidine ketoenol compound and ethiprole |
| 08/24/2006 | CA2599046A1 Antitumor agent |
| 08/24/2006 | CA2597594A1 Azolylacylguanidines as beta-secretase inhibitors |
| 08/24/2006 | CA2597033A1 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics |
| 08/24/2006 | CA2586925A1 Synthetic process for aminocyclohexyl ether compounds |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1693364A1 Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates |
| 08/23/2006 | EP1692110A1 Diacylhydrazine derivatives |
| 08/23/2006 | EP1692104A1 Methods of preparing compounds useful as protease inhibitors |
| 08/23/2006 | EP1692094A2 Bottom antireflective coatings |
| 08/23/2006 | EP1692090A1 Conversion of amine- to carboxyl groups on solid surfaces |
| 08/23/2006 | EP1691803A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | CN1823061A Pyrrole-2, 5-dione derivatives as liver X receptor modulators |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1271051C Aza aromatic ring substitutional four branched functional molecule material and preparation method |
| 08/23/2006 | CN1271050C Process for preparing 2-substituted enamine or enoyl amine |
| 08/23/2006 | CN1271030C Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1-yl)-phenoxy-ethyl-pyrrolidine |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094872 Activated polyethylene glycol esters |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094791 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/17/2006 | WO2006084996A1 Substituted pyrroles, compositions containing same, method for making same and use thereof |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | US20060183888 Pyrrolysine synthesis and modification |
| 08/17/2006 | US20060183790 e.g. N-[amino(imino)methyl]-2-[2-(4-phenoxyphenyl)-5-phenyl-1H-pyrrol-1-yl]acetamide; beta -amyloid deposits and neurofibrillary tangles; cognition activator, neurodegenerative diseases; Alzheimer's disease, Down's syndrome |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | CA2596822A1 Substituted pyrroles, compositions containing same, method for making same and use thereof |
| 08/17/2006 | CA2594662A1 Mitotic kinesin inhibitors |
| 08/16/2006 | EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/16/2006 | EP1689729A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 08/16/2006 | EP1689713A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 08/16/2006 | EP1689709A1 N-sulfonyldicarboximide containing tethering compounds |
| 08/16/2006 | EP1689708A1 N-acyl-n -benzyl-alkylendiamino derivatives |
| 08/16/2006 | EP1689706A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 08/16/2006 | EP1689702A1 Organic compounds |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1171123B1 Method for treating neurodegeneration |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820003A Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 08/16/2006 | CN1819994A KAPPA agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome |
| 08/16/2006 | CN1817859A Synthesis of tenuazonic acid and iso-tenuazonic acid |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/16/2006 | CN1269793C Method for producing 3,3-diarylpropylamines |
| 08/16/2006 | CN1269776C Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091306 Preparing a polyalkenyl derivative of an unsaturated acidic reagent; reacting the unfiltered product with a polyamine having at least one basic nitrogen atom; diluting the product; and subsequently filtering the polyalkenylsuccinimide product |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091245 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7090902 Ink jet recording material |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/10/2006 | WO2006083266A1 Inhibitors of bacterial type iii protein secretion systems |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082309A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer |
| 08/10/2006 | US20060178490 Catalysts containing N-pyrrolyl substituted nitrogen donors |
| 08/10/2006 | US20060178426 Kappa agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome |
| 08/10/2006 | US20060178425 Fungicidal carboxamides |
| 08/10/2006 | US20060178419 3-Sulfonylamino-pyrrolindine -2- one derivatives as inhibitors of factor xa |
| 08/10/2006 | US20060178414 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide |
| 08/10/2006 | US20060178403 Antiobesity agent, antidepressants, anxiolytic agents;3-[4-OXO-4H-THIENO[3,2-D]PYRIMIDIN-3-YL]-PYRROLIDINE-1-CARBOXYLIC ACID [1-(PYRROLIDIN-3-YL]-METHYL-AMIDES |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178369 Cinnamic acid amides |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 08/10/2006 | CA2595987A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer |
| 08/09/2006 | EP1687288A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 08/09/2006 | EP1687269A1 Cosmetic process for preventing or treating the signs of skin ageing or the orange-peel appearance |
| 08/09/2006 | EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 08/09/2006 | EP1686856A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides |
| 08/09/2006 | EP1546673A4 Novel green and orange fluorescent labels and their uses |
| 08/09/2006 | EP1224168B1 Antifungal enediynes |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | CN1816544A Immunosuppressant compounds and compositions |
| 08/09/2006 | CN1816332A 3-aminomethyl-pyrrolidines as N-type calcium channel blockers |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268611C Method of preparing 4-hydroxy pyrrolidone-2-acetamine |
| 08/09/2006 | CN1268332C Kappa opiate agonists for treatment of bladder diseases |
| 08/08/2006 | US7087770 Compound containing a labile disulfide bond |
| 08/08/2006 | US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087638 Plant safening agents; |
| 08/08/2006 | US7087594 Alkyl ether derivatives or salts thereof |
| 08/08/2006 | US7087229 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |